JAPAN – Canon Medical Systems Corporation and Olympus Corporation have partnered on Endoscopic Ultrasound systems in a move to facilitate the early detection of diseases and improve patient’s quality of life.
Under the new agreement, Canon Medical will develop and manufacture diagnostic ultrasound systems used in Endoscopic Ultrasonography (EUS) while Olympus will perform the sales and marketing efforts
The focal point of this collaboration is to provide the global market with advanced EUS equipment capable of delivering high-quality image diagnoses.
With plans for global expansion, starting in Japan and Europe, Canon Medical and Olympus are focusing on technological advancements and enhancing diagnostic performance in the EUS field.
“We are very pleased to collaborate with Olympus in the EUS field, which we have not been able to cover adequately until now, to deliver superior solutions to more patients,” Toshio Takiguchi, President and Chief Executive Officer of Canon Medical Systems Corporation, said in a statement.
With over 100 years in the diagnostic imaging systems business, Canon Medical provides products and services to more than 150 countries and regions worldwide.
Its products and services span across the entire diagnostic imaging chain, including X-ray diagnostic systems, CT, MRI, and ultrasound diagnostic systems.
For his part, Toshio Takiguchi outlined: “We have a long history in diagnostic ultrasound systems and have developed unique technologies that contribute to the early detection of diseases in cooperation with doctors around the world.”
It is worth highlighting that the Endoscopic Ultrasonography examination uses ultrasound attached to the tip of an endoscope to observe the outer organs, including the pancreas, gallbladder, bile ducts, and liver, from the stomach and duodenum.
In the diagnosis of pancreatic cancer, EUS is recognized as having the same diagnostic capability as contrast-enhanced Computed Tomography (CT) scan and Magnetic Resonance Imaging (MRI) scan in the Guidelines for Pancreatic Cancer Treatment (2022) in Japan.
This test collects tumor cells using an ultrasound endoscope thus enabling qualitative tissue diagnosis by minimally invasive cell and tissue collection.
Consequently, the deployment of Canon’s Aplio i8002 diagnostic ultrasound system for EUS and Olympus’ Ultrasound Endoscope marks a key milestone in the two companies’ efforts to maintain a high share of the global market.
“We have been promoting our business with diagnostic imaging at its core under the philosophy of Made for Life, which expresses our desire to contribute to medical care that protects precious lives,” Toshio Takiguchi affirmed patients and their families.
Through the latest collaboration, Canon Medical and Olympus will work closely to increase access to Canon’s Aplio i8002 diagnostic ultrasound system for EUS and Olympus’ Ultrasound Endoscope in Japan and Europe.
The two companies are projected to achieve further qualitative improvements in the quality of images and performance in diagnosis and minimally invasive treatment of EUS.
In the field of EUS, Olympus has worked closely with physicians to develop new equipment to enhance imaging and diagnostic methods and expand procedures.
The global MedTech company has contributed to elevating the standard of care through early detection, diagnosis and staging, and minimally invasive treatment since developing the world’s first practical gastrocamera.
For his part, Frank Drewalowski, Executive Officer and Endoscopic Solutions Division Head at Olympus Corporation, said: “Olympus aims to improve patients’ quality of life through early diagnosis made available with Endoscopic Ultrasound Systems.”
Frank Drewalowski emphasized on the significance of diagnostic ultrasound systems while lauding Olympus’ cooperative relationship with Canon Medical, which has advanced ultrasound imaging technology.
“Canon Medical and Olympus will continue to introduce products and technology that address the needs of the patients, healthcare professionals, and the broader medical industry,” highlighted Drewalowski.